These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 19454660)

  • 1. Functionally distinct LAG-3 and PD-1 subsets on activated and chronically stimulated CD8 T cells.
    Grosso JF; Goldberg MV; Getnet D; Bruno TC; Yen HR; Pyle KJ; Hipkiss E; Vignali DA; Pardoll DM; Drake CG
    J Immunol; 2009 Jun; 182(11):6659-69. PubMed ID: 19454660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.
    Lucas CL; Workman CJ; Beyaz S; LoCascio S; Zhao G; Vignali DA; Sykes M
    Blood; 2011 May; 117(20):5532-40. PubMed ID: 21422469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of PD-1 and LAG-3 Immune Checkpoints Combined with Vaccination Restores the Function of Antiviral Tissue-Resident CD8
    Roy S; Coulon PG; Prakash S; Srivastava R; Geertsema R; Dhanushkodi N; Lam C; Nguyen V; Gorospe E; Nguyen AM; Salazar S; Alomari NI; Warsi WR; BenMohamed L
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31217250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.
    Matsuzaki J; Gnjatic S; Mhawech-Fauceglia P; Beck A; Miller A; Tsuji T; Eppolito C; Qian F; Lele S; Shrikant P; Old LJ; Odunsi K
    Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7875-80. PubMed ID: 20385810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAG-3 regulates CD8+ T cell accumulation and effector function in murine self- and tumor-tolerance systems.
    Grosso JF; Kelleher CC; Harris TJ; Maris CH; Hipkiss EL; De Marzo A; Anders R; Netto G; Getnet D; Bruno TC; Goldberg MV; Pardoll DM; Drake CG
    J Clin Invest; 2007 Nov; 117(11):3383-92. PubMed ID: 17932562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells.
    Lichtenegger FS; Rothe M; Schnorfeil FM; Deiser K; Krupka C; Augsberger C; Schlüter M; Neitz J; Subklewe M
    Front Immunol; 2018; 9():385. PubMed ID: 29535740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinomas escape immune surveillance via inducing chronic activation and exhaustion of CD8+ T Cells co-expressing PD-1 and LAG-3 inhibitory receptors.
    Mishra AK; Kadoishi T; Wang X; Driver E; Chen Z; Wang XJ; Wang JH
    Oncotarget; 2016 Dec; 7(49):81341-81356. PubMed ID: 27835902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade.
    Reynoso ED; Elpek KG; Francisco L; Bronson R; Bellemare-Pelletier A; Sharpe AH; Freeman GJ; Turley SJ
    J Immunol; 2009 Feb; 182(4):2102-12. PubMed ID: 19201863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1 is a regulator of NY-ESO-1-specific CD8+ T cell expansion in melanoma patients.
    Fourcade J; Kudela P; Sun Z; Shen H; Land SR; Lenzner D; Guillaume P; Luescher IF; Sander C; Ferrone S; Kirkwood JM; Zarour HM
    J Immunol; 2009 May; 182(9):5240-9. PubMed ID: 19380770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection.
    Richter K; Agnellini P; Oxenius A
    Int Immunol; 2010 Jan; 22(1):13-23. PubMed ID: 19880580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1 signalling in CD4(+) T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced tolerance.
    Konkel JE; Frommer F; Leech MD; Yagita H; Waisman A; Anderton SM
    Immunology; 2010 May; 130(1):92-102. PubMed ID: 20113370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The upregulation of LAG-3 on T cells defines a subpopulation with functional exhaustion and correlates with disease progression in HIV-infected subjects.
    Tian X; Zhang A; Qiu C; Wang W; Yang Y; Qiu C; Liu A; Zhu L; Yuan S; Hu H; Wang W; Wei Q; Zhang X; Xu J
    J Immunol; 2015 Apr; 194(8):3873-82. PubMed ID: 25780040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection.
    Erickson JJ; Rogers MC; Hastings AK; Tollefson SJ; Williams JV
    J Immunol; 2014 Nov; 193(10):5108-17. PubMed ID: 25339663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAG-3 and PD-1 synergize on CD8
    Andrews LP; Butler SC; Cui J; Cillo AR; Cardello C; Liu C; Brunazzi EA; Baessler A; Xie B; Kunning SR; Ngiow SF; Huang YJ; Manne S; Sharpe AH; Delgoffe GM; Wherry EJ; Kirkwood JM; Bruno TC; Workman CJ; Vignali DAA
    Cell; 2024 Aug; 187(16):4355-4372.e22. PubMed ID: 39121848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-1 and LAG-3 blockade improve anti-tumor vaccine efficacy.
    Zahm CD; Moseman JE; Delmastro LE; G Mcneel D
    Oncoimmunology; 2021 Apr; 10(1):1912892. PubMed ID: 33996265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durable adoptive immunotherapy for leukemia produced by manipulation of multiple regulatory pathways of CD8+ T-cell tolerance.
    Berrien-Elliott MM; Jackson SR; Meyer JM; Rouskey CJ; Nguyen TL; Yagita H; Greenberg PD; DiPaolo RJ; Teague RM
    Cancer Res; 2013 Jan; 73(2):605-16. PubMed ID: 23188506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction.
    Rouhani SJ; Eccles JD; Riccardi P; Peske JD; Tewalt EF; Cohen JN; Liblau R; Mäkinen T; Engelhard VH
    Nat Commun; 2015 Apr; 6():6771. PubMed ID: 25857745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells.
    Maçon-Lemaître L; Triebel F
    Immunology; 2005 Jun; 115(2):170-8. PubMed ID: 15885122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells.
    Bak SP; Barnkob MS; Bai A; Higham EM; Wittrup KD; Chen J
    J Immunol; 2012 Aug; 189(4):1708-16. PubMed ID: 22798683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.